CBD Versus NSAIDs for Dog Joint Pain Relief: My Call

By Lauren Cochran, DVM, DACVIM

Comparisons · August 14, 2026 · 6 min read

CBD is a reasonable add-on for mild joint stiffness, but NSAIDs remain the better-proven choice for a dog in real arthritic pain.

Is CBD as good as an NSAID for a dog with sore joints? No — not if we’re talking about a dog with confirmed osteoarthritis and real pain on movement. That’s my call up front, and I’ll walk through why.

I want to be honest about where I land here, because it isn’t the popular answer among owners who’ve had a bad experience with a prescription drug. NSAIDs like carprofen have decades of controlled trials behind them, a well-mapped side-effect profile, and a dose your vet can titrate to your dog’s exact weight and kidney function. CBD has real, promising data — I’m not dismissing it — but the evidence is still thinner, and none of it puts CBD ahead of an NSAID for pain that’s actually limiting a dog’s mobility.

What the NSAID evidence actually shows

Carprofen is one of the most studied veterinary NSAIDs, and the comfort level with its efficacy in canine osteoarthritis is genuinely high. In efficacy trials, twice-daily dosing produced measurable improvement in lameness and weight-bearing without significant adverse reactions in the study population, and the drug class is described as anti-inflammatory, analgesic, and antipyretic — it hits pain from more than one angle. That’s a meaningfully different mechanism than CBD, which works mostly through modulation of pain signaling rather than blocking the inflammatory cascade the way an NSAID does.

The safety side isn’t spotless, and I don’t pretend it is. Gastrointestinal ulceration, and hepatic or renal compromise, are the real risks with this drug class, and owners are right to ask about them. A 2016 survey of UK owners and vets in the Journal of Small Animal Practice found that adverse-event concern is one of the biggest reasons owners hesitate to use NSAIDs long-term, even when their dog’s pain is significant. That hesitation is legitimate, but it’s also why bloodwork monitoring exists — most drug-related reactions resolve once the NSAID is stopped and the dog gets veterinary care.

Where CBD’s evidence actually holds up

CBD is not nothing. A randomized, double-blind, placebo-controlled study on CBD for canine osteoarthritis pain, published via PubMed, reported a significant reduction in owner-assessed pain and improved mobility scores in dogs receiving CBD alongside their usual care. That’s a real, controlled result, and it’s the strongest single piece of evidence in CBD’s favor.

But look closely at what the follow-up work says. A crossover study in the Frontiers in Veterinary Science pharmacokinetics and safety trial found CBD reasonably well tolerated at the doses tested, with elevated alkaline phosphatase as the main lab finding to watch. More recent work evaluating CBD given alongside NSAIDs, published in PMC, looked at whether CBD adds anything on top of conventional pain medication for dogs with mobility disorders — a more clinically honest question than CBD alone versus placebo. The pattern across this body of work: subjective owner-reported pain scores tend to improve with CBD, but the studies that used objective, instrumented gait or activity measurements have not consistently shown the same effect. That gap between what owners report and what force plates or accelerometers pick up is exactly why I keep CBD in the “supportive, not primary” category.

A dog I think about often

I once worked with a twelve-year-old Labrador, about 78 pounds, whose owner had noticed him hesitating at the bottom of the deck stairs every morning for about three weeks before the visit. He wasn’t limping outright — he was just slower to commit to the first step, and he’d stopped jumping into the car entirely. The owner had already tried a CBD chew from a big-box pet store for about a month with no clear change, and she was nervous about NSAIDs because a neighbor’s dog had had a bad GI reaction to one years earlier. We ran baseline bloodwork, confirmed his kidney and liver values were normal, and started him on a low-dose NSAID with a recheck in two weeks. By that recheck he was jumping into the car again and taking the stairs at a normal pace. That’s one dog, not a trial — but it’s the pattern I see most often when CBD alone hasn’t moved the needle and true osteoarthritic pain is present.

The counterargument, and why I still land where I do

The strongest case against my position is real: some dogs genuinely cannot tolerate NSAIDs, whether from prior kidney disease, a history of GI ulceration, or an owner who’s already seen a bad reaction firsthand. For those dogs, CBD — alongside weight management, physical rehab, and other non-NSAID options — is a legitimate part of the plan, and I use it that way regularly. I’m also not blind to the fact that safety concerns are one of the most-cited reasons owners avoid NSAIDs, per that UK survey. Concern isn’t the same as harm, but it’s a real barrier to a treatment that otherwise works.

Where I part ways with the “CBD instead of NSAIDs” framing is when a dog has confirmed, imaging-supported osteoarthritis with a clear pain response on exam. In that dog, the objective evidence still favors the drug class with the deeper efficacy record. If you’re trying to sort out whether what you’re seeing is early arthritis or just normal aging stiffness in the first place, our guide on arthritis versus normal aging stiffness in dogs walks through the gait patterns that actually distinguish the two.

There’s also a liver-safety wrinkle worth naming plainly. The Merck Veterinary Manual notes that elevated liver enzymes are a recognized finding with CBD exposure in dogs, which is exactly why any dog on CBD long-term — especially alongside an NSAID — needs periodic bloodwork, not a “set it and forget it” approach. And the FDA has been clear that CBD products are not FDA-approved for animal use and that quality and dosing accuracy vary widely across the market, which matters more than most owners assume when they’re comparing a supplement to a regulated prescription drug.

A practical sequence I actually recommend

Start with a real diagnosis, not a guess from the internet. Get your dog examined, and if arthritis is suspected, ask about imaging.

From there: if pain is mild and your dog tolerates NSAIDs poorly or not at all, CBD plus supportive care (weight control, joint supplements, rehab) is reasonable. If pain is moderate to severe and your dog has no contraindications, an NSAID under veterinary monitoring is still the better-supported first move — and CBD can be layered in as an adjunct once the NSAID’s baseline effect is established, which is closer to how the newer combined-treatment research is actually designed. If you’re weighing where to source either product, our comparison of Amazon Marketplace versus brand-direct websites for buying dog supplements is worth a look before you buy CBD from an unfamiliar seller.

Where this leaves the decision

If your dog is genuinely painful, don’t let CBD be the only thing you try before calling your vet. Ask for an exam, ask about NSAID options and the monitoring that goes with them, and treat CBD as a tool you can layer in rather than a replacement for a proven drug class. The next few years of veterinary cannabinoid research should sharpen exactly which dogs benefit most from CBD and at what dose — until then, I’ll keep making that call case by case, on the exam-room evidence in front of me.